Human Tissue Authority Launches Strategy for 2024-2027
The Human Tissue Authority (HTA) has today published its strategy for 2024-2027, setting out its vision and priorities for regulating the use of human tissue over the next three years.
We will adopt a new approach to regulation from September 2024 when most on-site assessments of HTA post mortem licensed premises will be taking place without notice.
Please see regulatory update 003/2024 for further information.
The HTA Board meeting held in public will take place on Thursday 19 September 2024. This page includes the agenda and papers.
HTA publishes a review of achievements for 2023/24.
HTA licensed establishments in the Post-mortem, Human Application and Organ Donation and Transplantation sector are required to report incidents to the HTA.
How to report them are different for each sector.